229 related articles for article (PubMed ID: 22964464)
1. Targeted inhibition of renal Rho kinase reduces macrophage infiltration and lymphangiogenesis in acute renal allograft rejection.
Poosti F; Yazdani S; Dolman ME; Kok RJ; Chen C; Ding G; Lacombe M; Prakash J; van den Born J; Hillebrands JL; van Goor H; de Borst MH
Eur J Pharmacol; 2012 Nov; 694(1-3):111-9. PubMed ID: 22964464
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effect of Y-27632 on chronic allograft nephropathy in rats.
Liu M; Gu M; Wu Y; Zhu P; Zhang W; Yin C; Zhang WJ
J Surg Res; 2009 Nov; 157(1):e117-27. PubMed ID: 19589538
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of renal rho kinase attenuates ischemia/reperfusion-induced injury.
Prakash J; de Borst MH; Lacombe M; Opdam F; Klok PA; van Goor H; Meijer DK; Moolenaar F; Poelstra K; Kok RJ
J Am Soc Nephrol; 2008 Nov; 19(11):2086-97. PubMed ID: 18650485
[TBL] [Abstract][Full Text] [Related]
4. Rho kinase pathway is likely responsible for the profibrotic actions of aldosterone in renal epithelial cells via inducing epithelial-mesenchymal transition and extracellular matrix excretion.
Wei J; Li Z; Ma C; Zhan F; Wu W; Han H; Huang Y; Li W; Chen D; Peng Y
Cell Biol Int; 2013 Jul; 37(7):725-30. PubMed ID: 23456826
[TBL] [Abstract][Full Text] [Related]
5. Reduction of fibrogenesis by selective delivery of a Rho kinase inhibitor to hepatic stellate cells in mice.
van Beuge MM; Prakash J; Lacombe M; Gosens R; Post E; Reker-Smit C; Beljaars L; Poelstra K
J Pharmacol Exp Ther; 2011 Jun; 337(3):628-35. PubMed ID: 21383021
[TBL] [Abstract][Full Text] [Related]
6. Macrophages contribute to cellular but not humoral mechanisms of acute rejection in rat renal allografts.
Ma FY; Woodman N; Mulley WR; Kanellis J; Nikolic-Paterson DJ
Transplantation; 2013 Dec; 96(11):949-57. PubMed ID: 24056626
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K
Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
[TBL] [Abstract][Full Text] [Related]
8. c-Jun NH2-terminal kinase is crucially involved in renal tubulo-interstitial inflammation.
de Borst MH; Prakash J; Sandovici M; Klok PA; Hamming I; Kok RJ; Navis G; van Goor H
J Pharmacol Exp Ther; 2009 Dec; 331(3):896-905. PubMed ID: 19717791
[TBL] [Abstract][Full Text] [Related]
9. Matrix-independent stimulation of human tubular epithelial cell migration by Rho kinase inhibitors.
Kroening S; Stix J; Keller C; Streiff C; Goppelt-Struebe M
J Cell Physiol; 2010 Jun; 223(3):703-12. PubMed ID: 20175114
[TBL] [Abstract][Full Text] [Related]
10. Macrophage colony-stimulating factor expression and macrophage accumulation in renal allograft rejection.
Le Meur Y; Jose MD; Mu W; Atkins RC; Chadban SJ
Transplantation; 2002 Apr; 73(8):1318-24. PubMed ID: 11981428
[TBL] [Abstract][Full Text] [Related]
11. Macrophage-derived interleukin-18 in experimental renal allograft rejection.
Wyburn K; Wu H; Yin J; Jose M; Eris J; Chadban S
Nephrol Dial Transplant; 2005 Apr; 20(4):699-706. PubMed ID: 15716294
[TBL] [Abstract][Full Text] [Related]
12. Signaling Rho-kinase mediates inflammation and apoptosis in T cells and renal tubules in cisplatin nephrotoxicity.
Nozaki Y; Kinoshita K; Hino S; Yano T; Niki K; Hirooka Y; Kishimoto K; Funauchi M; Matsumura I
Am J Physiol Renal Physiol; 2015 Apr; 308(8):F899-909. PubMed ID: 25651561
[TBL] [Abstract][Full Text] [Related]
13. Spleen tyrosine kinase contributes to acute renal allograft rejection in the rat.
Ramessur Chandran S; Tesch GH; Han Y; Woodman N; Mulley WR; Kanellis J; Blease K; Ma FY; Nikolic-Paterson DJ
Int J Exp Pathol; 2015 Feb; 96(1):54-62. PubMed ID: 25529862
[TBL] [Abstract][Full Text] [Related]
14. Rho-kinase mediates TNF-α-induced MCP-1 expression via p38 MAPK signaling pathway in mesangial cells.
Matoba K; Kawanami D; Ishizawa S; Kanazawa Y; Yokota T; Utsunomiya K
Biochem Biophys Res Commun; 2010 Nov; 402(4):725-30. PubMed ID: 20977889
[TBL] [Abstract][Full Text] [Related]
15. HSC-specific inhibition of Rho-kinase reduces portal pressure in cirrhotic rats without major systemic effects.
Klein S; Van Beuge MM; Granzow M; Beljaars L; Schierwagen R; Kilic S; Heidari I; Huss S; Sauerbruch T; Poelstra K; Trebicka J
J Hepatol; 2012 Dec; 57(6):1220-7. PubMed ID: 22878469
[TBL] [Abstract][Full Text] [Related]
16. ρ-Kinase inhibition reduces early microvascular leukocyte accumulation in the rat kidney following ischemia-reperfusion injury: roles of nitric oxide and blood flow.
Versteilen AM; Blaauw N; Di Maggio F; Groeneveld AB; Sipkema P; Musters RJ; Tangelder GJ
Nephron Exp Nephrol; 2011; 118(4):e79-86. PubMed ID: 21311198
[TBL] [Abstract][Full Text] [Related]
17. Rho-kinase inhibitor upregulates migration by altering focal adhesion formation via the Akt pathway in colon cancer cells.
Adachi S; Yasuda I; Nakashima M; Yamauchi T; Yoshioka T; Okano Y; Moriwaki H; Kozawa O
Eur J Pharmacol; 2011 Jan; 650(1):145-50. PubMed ID: 20959118
[TBL] [Abstract][Full Text] [Related]
18. Distribution and expression of fibroblast-specific protein chemokine CCL21 and chemokine receptor CCR7 in renal allografts.
Zhou HL; Wang YT; Gao T; Wang WG; Wang YS
Transplant Proc; 2013 Mar; 45(2):538-45. PubMed ID: 23498789
[TBL] [Abstract][Full Text] [Related]
19. Rho kinase inhibition following traumatic brain injury in mice promotes functional improvement and acute neuron survival but has little effect on neurogenesis, glial responses or neuroinflammation.
Bye N; Christie KJ; Turbic A; Basrai HS; Turnley AM
Exp Neurol; 2016 May; 279():86-95. PubMed ID: 26896832
[TBL] [Abstract][Full Text] [Related]
20. Rho kinase inhibition attenuates LPS-induced renal failure in mice in part by attenuation of NF-kappaB p65 signaling.
Meyer-Schwesinger C; Dehde S; von Ruffer C; Gatzemeier S; Klug P; Wenzel UO; Stahl RA; Thaiss F; Meyer TN
Am J Physiol Renal Physiol; 2009 May; 296(5):F1088-99. PubMed ID: 19225047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
